The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscle
Open accessAbstract
This study investigates the effects of gastric inhibitory polypeptide (GIP) and glycated GIP (glucitol adduct of GIP) on glucose uptake and metabolism in muscle. Glycated GIP (molecular mass 5147.2 Da) was purified by HPLC following in vitro incubation under hyperglycaemic reducing conditions (24 h at pH 7.4). GIP (10(-10)-10(-8) mol/l) significantly stimulated (1.4- to 1.5-fold, P < 0.001) 2-deoxy-D-[1-3H]glucose uptake in abdominal muscle pieces from 3- to 5-week-old lean mice compared with control incubations (without GIP). This stimulatory effect on glucose uptake at 10(-10)-10(-9) mol/l was decreased by 13-20% following glycation of the peptide (P < 0.05). GIP (10(-9) and 10(-8) mol/l) induced a stepwise 1.4- to 1.7-fold increase (P < 0.01, P < 0.001 respectively) in [14C]glucose oxidation compared with controls. This effect on glucose oxidation was diminished by 32% with 10(-8) mol/l glycated GIP (P < 0.05). GIP (10(-9) and 10(-8) mol/l) induced a 1.4- to 1.8-fold increase in [14C]glucose incorporation into muscle glycogen (glycogenesis) compared with controls. Glycated GIP (10(-8) mol/l) exhibited a 41% decrease in glycogenic activity (P < 0.01). GIP (10(-10)-10(-8) mol/l) stimulated lactate production in isolated abdominal muscle (1.2- to 1.3-fold, P < 0.05); however glycated GIP did not exert a significant effect. This study demonstrates for the first time that GIP promotes glucose uptake, glucose oxidation and glycogenesis in muscle tissue. Furthermore, modification of GIP through glycation diminishes its biological effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“O’Harte et al. showed that GIP enhanced glucose transport in the mouse diaphragm [56].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [56]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Comparative biochemistry and physiology
(1975) · Comparative Biochemistry and Physiology Part B: Comparative Biochemistry · doi:10.1016/0305-0491(75)90161-3 · Cited by 779
Usdin, T. B., Mezey, E., Button, D. C., Brownstein, M. J., & Bonner, T. I. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243312 · Cited by 534 · cited 2×
“Receptors for GIP have been described in a number of tissues including human insulinomas (Maletti et al. 1986) as well as in endocrine pancreas, stomach, proximal small intestine, adipose tissue, adrenal gland, brain and pituitary ( Usdin et al. 1993, Moens et al. 1996) but not to our knowledge in skeletal muscle.”
BackgroundFEHMANN, H.-C., GÖKE, R., & GÖKE, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 528 · cited 1×
“…action of GIP makes a major contribution to its metabolic role, direct effects of GIP at extrapancreatic sites, including stomach, liver and adipose tissue, have been suggested to contribute to the overall action of the hormone on post-prandial nutrient homeostasis (Fehmann et al. 1995).”
BackgroundFurther purification of a polypeptide demonstrating enterogastrone activity
Brown, J. C., Mutt, V., & Pederson, R. A. (1970) · The Journal of Physiology · doi:10.1113/jphysiol.1970.sp009155 · Cited by 276 · cited 2×
“The forty-two amino acid GIP was initially isolated from porcine intestine for its ability to inhibit gastric acid secretion (Brown et al. 1970), but its most important physiological role resides in its insulinotrophic activity (Morgan et al. 1988).”
BackgroundMoens, K., Heimberg, H., Flamez, D., Huypens, P., Quartier, E., Ling, Z., Pipeleers, D., Gremlich, S., Thorens, B., & Schuit, F. (1996) · Diabetes · doi:10.2337/diab.45.2.257 · Cited by 250 · cited 2×
“Receptors for GIP have been described in a number of tissues including human insulinomas (Maletti et al. 1986) as well as in endocrine pancreas, stomach, proximal small intestine, adipose tissue, adrenal gland, brain and pituitary (Usdin et al. 1993, Moens et al. 1996 ) but not to our knowledge in skeletal muscle.”
BackgroundOral Glucose Augmentation of Insulin Secretion
Andersen, D. K., Elahi, D., Brown, J. C., Tobin, J. D., & Andres, R. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109100 · Cited by 240 · cited 2×
“1995) to stimulate insulin secretion and enhance proinsulin gene expression (Andersen et al. 1978).”
BackgroundGastric Inhibitory Polypeptide (GIP) Stimulation by Oral Glucose in Man
CATALAND, S., CROCKETT, S. E., BROWN, J. C., & MAZZAFERRI, E. L. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-2-223 · Cited by 227 · cited 2×
“Oral glucose is absorbed from the small intestine through an active sodium- dependent transport mechanism resulting in a sharp rise in plasma immunoreactive GIP and insulin concentrations (Cataland et al. 1974).”
BackgroundGastric Inhibitory Polypeptide Enhanced Lipoprotein Lipase Activity in Cultured Preadipocytes
Eckel, R. H., Fujimoto, W. Y., & Brunzell, J. D. (1979) · Diabetes · doi:10.2337/diab.28.12.1141 · Cited by 219 · cited 1×
“These include the stimulation of glucose uptake in adipocytes, increased synthesis of fatty acids and activation of lipoprotein lipase in adipose tissue (Eckel et al. 1979, Oben et al. 1991, Morgan 1996).”
BackgroundOben, J., Morgan, L., Fletcher, J., & Marks, V. (1991) · Journal of Endocrinology · doi:10.1677/joe.0.1300267 · Cited by 188 · cited 1×
“These include the stimulation of glucose uptake in adipocytes, increased synthesis of fatty acids and activation of lipoprotein lipase in adipose tissue (Eckel et al. 1979, Oben et al. 1991, Morgan 1996).”
Background
Research works printed but not linked: 3
- Elahi D, Meneilly GS, Minaker KL, Rowe JW & Andersen DK 1986 Regulation of hepatic glucose production by gastric inhibitory polypeptide in man. In Proceedings of the Sixth International Conference on Gastrointestinal Hormones, Vancouver, BC, p 18. Ottawa: National Research Council of Canadian Research Journals.
- Flatt PR, Kwasowski P, Howland RJ & Bailey CJ 1991 Gastric inhibitory polypeptide and insulin responses to orally administered amino acids in genetically obese hyperglycaemic (ob/ob) mice. Journal of Nutrition 121 1123-1128.
- Schmidt WE, Siegel EG, Ebert R & Creutzfeldt W 1986 N-terminal tyrosine-alanine is required for the insulin releasing activity of glucose-dependent insulinotropic polypeptide. European Journal of Clinical Investigation 16 A9.
Cited by
Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor
Parthier, C., Kleinschmidt, M., Neumann, P., Rudolph, R., Manhart, S., Schlenzig, D., Fanghänel, J., Rahfeld, J.-U., Demuth, H.-U., & Stubbs, M. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706404104 · Cited by 232
Gault, V. A., Irwin, N., Green, B. D., McCluskey, J. T., Greer, B., Bailey, C. J., Harriott, P., O’Harte, F. P. M., & Flatt, P. R. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2436 · Cited by 173
Self-citationChapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)
McIntosh, C. H. S., Widenmaier, S., & Kim, S. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00615-8 · Cited by 171
Deacon, C. F., Danielsen, P. L., Klarskov, L., Olesen, M., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1588 · Cited by 159
“GIP receptors have been identified in several tissues (34,35), and there are reports that GIP promotes glucose uptake in muscle (36) and fat (37–39).”
BackgroundHinke, S. A., Gelling, R. W., Pederson, R. A., Manhart, S., Nian, C., Demuth, H., & McIntosh, C. H. S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.652 · Cited by 142
Metadata
- Authors
- O'Harte, F., Gray, A., & Flatt, P.
- Affiliations
- University of Ulster (GB)
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 1998-02-01
- Volume
- 156
- Issue
- 2
- Pages
- 237-243
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2152960998
- Cited by
- 60
- References
- 37
- Citations by year
- 2025: 1 · 2024: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 1 · 2015: 1 · 2012: 1
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Aston University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- glucose-dependent insulinotropic polypeptide, glycation, glucose uptake, glucose oxidation, glycogen synthesis, muscle glycogen, lactic acid production, abdominal muscles, hyperglycemia, peptide modification, glucose metabolism
- MeSH terms
- Animals, Biological Transport, Gastric Inhibitory Polypeptide, Glucose, Glycogen, Glycosylation, Insulin, Male, Oxidation-Reduction, Stimulation, Chemical, Muscle, Skeletal, Lactic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscle. https://app.cochat.ai/papers/10.1677/joe.0.1560237
- The paper
- O'Harte, F., Gray, A., & Flatt, P. (1998). Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscle. Journal of Endocrinology. https://doi.org/10.1677/joe.0.1560237
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.